arrow
C

Carsten Lukas

St. Josef-Hospital
H指数:35
被引数:5,768

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimization of cervical cord atrophy measurement using a real-world; multicentre dataset in multiple sclerosis

利用真实世界、多中心数据集优化多发性硬化中颈髓萎缩的测量

2025-11-270
OAAI
Neurological disability and brain grey matter atrophy in primary progressive multiple sclerosis are determined by microstructural lesional changes, but not by lesion load

神经功能障碍和原发性进展型多发性硬化中大脑灰质萎缩由微结构病灶变化决定,而非由病灶负荷决定。

2025-04-010
OA
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis
2025-01-140
PRE
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease
2024-11-011
OA
A future of AI-driven personalized care for people with multiple sclerosis

人工智能驱动的多发性硬化症患者个性化护理的未来

2024-08-191
OAAI
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
2024-05-231
OAAI
Prognostic value of single-subject grey matter networks in early multiple sclerosis
BRAIN
IF11.7
2023-08-298
OAAI
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes
2023-06-155
OA
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
BRAIN
IF11.7
2022-12-1415
OA
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study

脊髓病变和脑灰质萎缩独立预测明确多发性硬化症的临床恶化: 一项为期5年的多中心研究

2022-09-2815
OA